PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryJul 28, 2011	Integra LifeSciences Reports Second Quarter 2011 Financial Results Revenues for the Second Quarter Increased to $193 Million	View HTML Integra LifeSciences Reports Second Quarter 2011 Financial Results 53.3 KB
Toggle SummaryJul 13, 2011	Integra LifeSciences Expands Uni-CP(TM) Compression System Product Range for Mid and Hindfoot Reconstruction PLAINSBORO, N.J., July 13, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will release a line extension for its Uni-CP™ Compression System. The Uni-CP™ Compression System provides a comprehensive solution for arthrodesis and fracture	View HTML Integra LifeSciences Expands Uni-CP(TM) Compression System Product Range for Mid and Hindfoot Reconstruction 12.3 KB
Toggle SummaryJul 6, 2011	Integra LifeSciences to Host Its Second Quarter 2011 Earnings Results Conference Call on July 28, 2011 PLAINSBORO, N.J., July 6, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2011 financial results on Thursday, July 28, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Second Quarter 2011 Earnings Results Conference Call on July 28, 2011 9.3 KB
Toggle SummaryJun 10, 2011	Integra Announces Pricing of Convertible Senior Notes PLAINSBORO, N.J., June 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the pricing of $200,000,000 aggregate principal amount of 1.625% convertible senior notes due 2016 (the "notes"). The notes were offered and sold in a private placement solely	View HTML Integra Announces Pricing of Convertible Senior Notes 12.3 KB
Toggle SummaryJun 9, 2011	Integra Announces Private Placement of Convertible Senior Notes PLAINSBORO, N.J., June 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has commenced a private offering, subject to market conditions, of $200,000,000 aggregate principal amount of convertible senior notes due 2016.	View HTML Integra Announces Private Placement of Convertible Senior Notes 12 KB
Toggle SummaryJun 8, 2011	Integra LifeSciences Lowers Costs and Extends Term of Its $600 Million Credit Facility PLAINSBORO, N.J., June 8, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under its credit facility, including lower pricing and an extended maturity date, with its bank group led by Bank of America, N.A and JPMorgan	View HTML Integra LifeSciences Lowers Costs and Extends Term of Its $600 Million Credit Facility 11.6 KB
Toggle SummaryMay 31, 2011	Integra LifeSciences to Present at Three Conferences in June PLAINSBORO, N.J., May 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in June as follows: On Tuesday, June 7, 2011 - At 10:00 AM ET, Mr. Stuart Essig, CEO of Integra, will present at the Jefferies 2011	View HTML Integra LifeSciences to Present at Three Conferences in June 11.3 KB
Toggle SummaryMay 24, 2011	Integra LifeSciences Acquires SeaSpine Integra Spine Doubles Its Distribution Network and Revenue Base in Spinal Hardware Kirt Stephenson Joins Integra as President, U.S. Spine PLAINSBORO, N.J., May 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired SeaSpine, Inc., a	View HTML Integra LifeSciences Acquires SeaSpine 15.5 KB
Toggle SummaryMay 4, 2011	Integra LifeSciences Announces Three-Year Contract With Novation to Provide Luxtec(R) Surgical Headlights PLAINSBORO, N.J., May 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract with Novation, the leading healthcare supply contracting company, to provide Luxtec® surgical headlights, light sources and accessories	View HTML Integra LifeSciences Announces Three-Year Contract With Novation to Provide Luxtec(R) Surgical Headlights 10.3 KB
Toggle SummaryApr 28, 2011	Integra LifeSciences Reports First Quarter 2011 Financial Results Revenues for the First Quarter Increased to $181 Million	View HTML Integra LifeSciences Reports First Quarter 2011 Financial Results 53.2 KB
Toggle SummaryApr 28, 2011	Integra LifeSciences to Present at the Deutsche Bank Health Care and the Bank of America Merrill Lynch Health Care Conferences PLAINSBORO, N.J., April 28, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in May as follows: On Monday, May 2, 2011 at 1:30 PM ET., Mr. Brian Larkin, President, Global Spine and Orthobiologics and Head of	View HTML Integra LifeSciences to Present at the Deutsche Bank Health Care and the Bank of America Merrill Lynch Health Care Conferences 11.4 KB
Toggle SummaryApr 18, 2011	Integra LifeSciences CFO Jack Henneman Selected as a 2011 SmartCXO Winner by Philadelphia SmartCEO Magazine PLAINSBORO, N.J., April 18, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced that John B. Henneman, III, Integra's Executive Vice President, Finance and Administration, and Chief Financial Officer, has been selected as one of ten winners in the Chief	View HTML Integra LifeSciences CFO Jack Henneman Selected as a 2011 SmartCXO Winner by Philadelphia SmartCEO Magazine 11.2 KB
Toggle SummaryApr 14, 2011	Integra LifeSciences Announces Instrument Repair Partnership With InstruMedics PLAINSBORO, N.J., April 14, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced a partnership with InstruMedics LLC., a national provider of service and repair for surgical instruments and equipment. The relationship will allow Integra's Surgical Instrument	View HTML Integra LifeSciences Announces Instrument Repair Partnership With InstruMedics 12.6 KB
Toggle SummaryApr 12, 2011	Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix PLAINSBORO, N.J., April 12, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market Accell Evo3 ® Demineralized Bone Matrix as a bone void filler	View HTML Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix 10.8 KB
Toggle SummaryApr 11, 2011	Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices PLAINSBORO, N.J., April 11, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510k clearance from the United States Food and Drug Administration (FDA) for three new spinal intervertebral body fusion devices (IBD), continuing to	View HTML Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices 10.5 KB